Читать «Трещина в мироздании» онлайн - страница 198
Сэмюел Стернберг
238
P. Berg et al., “Letter: Potential Biohazards of Recombinant DNA Molecules”,
239
Institute of Medicine (US) Committee to Study Decision Making; K. E. Hanna, ed.,
240
P. Berg et al., “Asilomar Conference on Recombinant DNA Molecules”,
241
P. Berg, “Meetings That Changed the World: Asilomar 1975: DNA Modification Secured”,
242
“After Asilomar”,
243
S. Jasanoff, J. B. Hurlbut, and K. Saha, “CRISPR Democracy: Gene Editing and the Need for Inclusive Deliberation”,
244
J. B. Hurlbut, “Limits of Responsibility: Genome Editing, Asilomar, and the Politics of Deliberation”,
245
N. A. Wivel, “Historical Perspectives Pertaining to the NIH Recombinant DNA Advisory Committee”,
246
D. Baltimore et al., “Biotechnology: A Prudent Path Forward for Genomic Engineering and Germline Gene Modification”,
247
N. Wade, “Scientists Seek Ban on Method of Editing the Human Genome”,
248
R. Stein, “Scientists Urge Temporary Moratorium on Human Genome Edits”,
249
E. Lanphier et al., “Don’t Edit the Human Germline”,
250
A. Regalado, “Engineering the Perfect Baby”,
251
P. Liang et al., “CRISPR/Cas9-Mediated Gene Editing in Human Tripronuclear Zygotes”,
252
P. Liang et al., “CRISPR/Cas9-Mediated Gene Editing in Human Tripronuclear Zygotes”,
253
X. Zhai, V. Ng, and R. Lie, “No Ethical Divide Between China and the West in Human Embryo Research”,
254
D. Cyranoski and S. Reardon, “Chinese Scientists Genetically Modify Human Embryos”,
255
G. Kolata, “Chinese Scientists Edit Genes of Human Embryos, Raising Concerns”,
256
T. Friedmann et al., “ASGCT and JSGT Joint Position Statement on Human Genomic Editing”,
257
R. Jaenisch, “A Moratorium on Human Gene Editing to Treat Disease Is Critical”,
258
J. Holdren, “A Note on Genome Editing”, May 26, 2015,
259
Francis S. Collins, “Statement on NIH Funding of Research Using Gene-Editing Technologies in Human Embryos”, April 29, 2015,